MedPath

KURUME UNIVERSITY

KURUME UNIVERSITY logo
πŸ‡―πŸ‡΅Japan
Ownership
Private
Established
1930-01-01
Employees
1K
Market Cap
-
Website
http://www.kurume-u.ac.jp

Clinical Trials

58

Active:0
Completed:47

Trial Phases

6 Phases

Early Phase 1:1
Phase 1:3
Phase 2:3
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (56 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
43 (76.8%)
Phase 4
4 (7.1%)
Phase 1
3 (5.4%)
Phase 2
3 (5.4%)
Phase 3
2 (3.6%)
Early Phase 1
1 (1.8%)

An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Transitioning to Lemborexant in Japanese Subjects With Insomnia

First Posted Date
2021-02-08
Last Posted Date
2023-03-15
Lead Sponsor
Kurume University
Target Recruit Count
97
Registration Number
NCT04742699
Locations
πŸ‡―πŸ‡΅

YOU ARIYOSHI Sleep Clinic, Kitakyushu, Fukuoka, Japan

πŸ‡―πŸ‡΅

Kurume University Hospital, Kurume, Fukuoka, Japan

πŸ‡―πŸ‡΅

Hirota Clinic, Kurume, Fukuoka, Japan

and more 6 locations

Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose Tissue

Phase 4
Conditions
Efficacy of Olmesartan on Cerebral Glucose Metabolism in Essential Hypertension
Interventions
First Posted Date
2016-12-19
Last Posted Date
2016-12-20
Lead Sponsor
Kurume University
Target Recruit Count
100
Registration Number
NCT02996916
Locations
πŸ‡―πŸ‡΅

Kurume University Hospital, Kurume, Japan

Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors

Phase 4
Conditions
Effects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications
Interventions
Drug: DPP-4 inhibiotors
Drug: SGLT2 inhibitors
First Posted Date
2015-08-19
Last Posted Date
2015-08-19
Lead Sponsor
Kurume University
Target Recruit Count
100
Registration Number
NCT02528019
Locations
πŸ‡―πŸ‡΅

Kurume University Hospital, Kurume city, Japan

Effects of Montelukast on Airway Regulatory T Cells in Asthma

Phase 2
Conditions
Asthma
Interventions
First Posted Date
2013-09-27
Last Posted Date
2013-09-27
Lead Sponsor
Kurume University
Target Recruit Count
15
Registration Number
NCT01951898
Locations
πŸ‡―πŸ‡΅

Kurume University School of Medicine, Kurume, Japan

Pioglitazone Decreases Visceral Fat Metabolism

Not Applicable
Conditions
To Evaluate the Effect of Pioglitazone on Glucose Metabolism of Fat Tissue by Using FDG-PET/CT Imaging
Interventions
First Posted Date
2013-03-27
Last Posted Date
2013-03-27
Lead Sponsor
Kurume University
Target Recruit Count
60
Registration Number
NCT01819402
Locations
πŸ‡―πŸ‡΅

Kurume University, Kurume, Japan

  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.